Elise A. Murphy FDA

Elise A. Murphy is a Branch Chief in the Division of Quality Surveillance Assessment, Office of Surveillance (OS), Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration in Silver Spring, MD.

Elise holds a Bachelor of Science degree in Chemistry from Chicago State University. She joined the Agency after three years in the private sector as a pharmaceutical chemist. Her FDA career began in 1991 as a review chemist in the Office of Generic Drugs in CDER.  In 1994, she transitioned to the Office of Regulatory Affairs where she worked as a Scientific Coordinator in the Division of Field Science. In 2003, she became Laboratory Director of the Philadelphia Laboratory.  During her tenure, she successfully led laboratory management personnel through the ISO 17025 accreditation process - American Association for Laboratory Accreditation.

In December 2009, she returned to CDER as a team lead then Branch Chief in the Office of Manufacturing Product Quality. She then transitioned over to the OPQ. In these positions, she played a critical role in re-defining the incident management process and post-market product quality reports in the CDER Office of Compliance and Office of Pharmaceutical Quality.